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ABSTRACT
Examination of intestines using methods of magnetic resonance (MR) enterography and MR enteroclysis is currently 
considered to be the best way to visualise diseases of the small intestine like Crohn’s disease, other inflammatory 
diseases of the small intestine, celiac disease, small intestine tumours, and cancers. They are both used in the initial 
diagnostics, assessment of the severity, as well as in monitoring of the course of the disease and possible complica-
tions. Both diagnostic methods require initial preparation of the patient by oral administration of a contrast agent. 
There are three types of oral contrast agents used in MR enterography and MR enteroclysis: positive, negative, and 
biphasic. In addition, an intravenous gadolinium contrast agent is administered during the study. MR enterography 
and MR enteroclysis allow accurate assessment of such structures as: the thickness of the intestinal wall, layering 
of the intestinal wall, narrowing, obstruction, gastrointestinal fistulas, gastrointestinal adipose tissue, encapsulated 
or free fluid in the abdomen, and lymph nodes. The undoubted advantages of these diagnostic methods include the 
lack of invasiveness, the possibility of obtaining multifaceted images, the possibility of assessing pathology not only 
within the intestine, but also in parenteral localisation, and the total absence of exposure of the patient to ionising 
radiation. The quality of the MR images obtained using both techniques depends largely on the correct preparation 
of the patient before the examination, in which the nurse participates to a large extent, leading the correct coopera-
tion of the patient with the medical staff performing the MRI examination.
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INTRODUCTION
In recent years, significant progress has been 
observed in the imaging diagnostics of the small in-
testine. Classical imaging techniques such as gastro-
intestinal passage using barium sulphate have been 
largely replaced by magnetic resonance imaging (MRI) 
techniques [1, 2]. Intestinal MRI tests, due to their 
specificity, require special involvement of medical 
staff, especially nurses. The nurse’s role is important 
due to the necessity of correct preparation of the pa-
tient prior to examination, preparation of the enteric 
contrast agent, monitoring appropriate hydration, 
overseeing possible complications associated with 
administration of the contrast agent (e.g. vomiting 
may occur in some patients), and aftercare following 
the examination due to the possibility of side effects 
(e.g. diarrhoea, hypotension).
Currently, there are two MRI techniques used in 
the imaging diagnostics of the small intestines: MR 
enterography and MR enteroclysis. Both methods 
are known as MRE, and both provide information on 
intestinal morphology (assessment of intestinal lu-
men and its wall) and surrounding tissues (intestinal 
fat, mesentery, lymph nodes). The main difference 
between these two imaging methods is the means 
of enteral administration of the contrast agent: in 
MR enteroclysis, the naso-intestinal probe is inserted 
into the duodenum near the Treitz ligament; while 
in MR enterography the agent is administered orally. 
Comparing both methods, it is worth noting that MR 
enteroclysis allows for a  better and more accurate 
assessment of the intestinal lumen – especially the 
jejunum; therefore, it is helpful in diagnosing inflam-
matory diseases and cancers of the small intestine. 
It can be used as a first-line examination technique. 
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MR enterography, on the other hand, is usually used to 
diagnose and monitor patients with Crohn’s disease, 
diseases without jejunum involvement, and is a meth-
od of choice in paediatric patients in whom insertion of 
the naso-intestinal probe may be problematic [1, 3-7].
MRI technique allows for early detection of struc-
tural intestinal abnormalities and assessment of the 
severity of changes, which in turn accelerates the 
treatment process and hence improves patient care.
Additional advantages of MRI techniques are 
avoidance of ionising radiation and achievement of 
multi-faceted imaging with high resolution. One of 
the most common indications for MRI of the small 
intestine is assessment of the severity of changes 
seen in patients with Crohn’s disease [4, 6-8]. Table 1 
shows indications for this type of imaging.
CONTRAST AGENTS USED  
IN INTESTINAL MRI
Enteric contrast agents used in the imaging of 
the small intestine must meet certain criteria. Their 
desirable characteristics include, among others: even 
distribution, appropriate expansion of the lumen of 
the small intestine, and achievement of high contrast 
between the lumen and the intestinal wall. Contrast 
agents should not be absorbed and should not stimu-
late intestinal peristalsis. They should be well toler-
ated and easy to use.
There are three main groups of oral and enteric 
contrast agents: positive contrast agents, negative 
contrast agents, and two-phase contrast agents.
Positive oral enteral contrast agents
Positive contrast agents have paramagnetic prop-
erties. They allow high intensity of intestinal content 
signal in T1 and T2 dependent images to be obtained 
by reducing T1 relaxation time. They also allow imag-
ing in the T1 sequence of the dependent thickening 
of the intestinal wall, but their disadvantage is the 
equalisation of the contrast between the intestinal 
lumen and the intestinal wall after intravenous ad-
ministration. Positive contrast agents include: gado-
linium chelates, manganese ions, ferrous ions, oily 
agents, e.g. corn oil, children’s conditioner, and low-
concentration barium suspensions. The use of these 
agents is not routinely recommended [1, 5, 7].
Negative oral enteral contrast agents
Negative contrast agents give low signal intensity 
on T2- and T1-dependent images. These include so-
lutions with superparamagnetic properties such as 
iron oxides (SPIO), diamagnetic contrast agents (high 
concentration barium sulphate), and agents with free 
protons, e.g. gases. Contrast agents containing su-
perparamagnetic iron particles had been withdrawn 
from use due to side effects such as diarrhoea and 
nausea [1, 5, 7].
Biphasic oral enteral contrast agents
Biphasic contrast agents give high or low signal 
intensity depending on the type of sequence used 
in the imaging process. They reduce the intensity of 
the lumen signal filled with the agent in the T1-de-
pendent sequence but increase in the T2-dependent 
sequence. The low signal intensity of these agents in 
T1-dependent sequences allows for improved con-
trast between intestinal lumen and, for example, an 
inflammatory wall after intravenous administration 
of the contrast agent. Similarly, the T2-dependent 
sequence without intravenous administration of the 
contrast agent results in better contrast imaging be-
tween high signal of intestinal lumen and low signal 
of intestinal wall.
These include substances containing manganese 
(blackcurrant juice, green tea), water, ferric ammo-
nium citrate, methyl cellulose, mannitol, polyethylene 
glycol, and sorbitol. Due to possible side effects such 
as nausea, vomiting, and diarrhoea, in some diagnos-
tic centres metoclopramide is used to minimise them 
[1, 2, 5, 7].
THE NURSE’S ROLE IN PATIENT 
PREPARATION FOR THE MRI EXAMINATION
Achievement of proper and good quality diag-
nostic images in MR enteroclysis and enterography 
requires appropriate preparation of a patient for the 
examination (hospital ward) or provision of correct 
information regarding home preparation prior to im-
aging appointment. An important role here is played 
by the nurse (MRI laboratory or hospital ward). The 
nurse provides all necessary information about the 
preparation and the entire examination to the pa-
tient. In addition, the nurse overlooks the proper 
course of the preparation for the study in the MRI 
laboratory.
Approximately 2-3 days before the examination, 
the patient should eat a  light digestible diet, some-
times even a  semi-liquid one, eliminating from the 
diet dairy products, meals rich in carbohydrates, as 
well as large quantities of food. The day before the 
examination (if the imaging is scheduled for the 
morning the next day) or on the day of the exami-
Table 1. Indications for MR intestine imaging
Indications
1. Crohn’s disease
2. Other inflammatory diseases of the small intestine
3. Celiac disease
4. Small intestine tumours and cancers
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nation (if the examination is scheduled for the after-
noon), the patient should perform a  rectal infusion 
using a ready-made enema kit. This is not necessary 
in most cases in patients who have diarrhoea. Before 
the intestinal MR examination, the patient should be 
fasting – without food for about 4-6 hours. Moreover, 
an intravenous contrast agent is used during the ex-
amination. Therefore, the patient must obtain renal 
function test results (creatinine level and eGFR) prior 
to date of the test [3].
The patient should report to the MRI laboratory 
about an hour before the scheduled date of the ex-
amination – the second part of patient preparation 
takes place in the laboratory under the supervision of 
a nurse. His or her tasks include preparation of the pa-
tient’s intravenous puncture (in the case of absence of 
any contraindications, the intravenous contrast agent 
is administered during the study) and preparation of 
the oral contrast agent, which the patient receives to 
drink (50-60 min before the scheduled time of the 
study) [3, 4]. The time of administration of the oral 
contrast agent should be recorded in the patient’s file. 
In the case of MR enterography, an appropriate pro-
portion of mannitol or sorbitol is diluted with water 
– the patient receives one litre of ready-made prepa-
ration to drink. In order to minimise motor artefacts 
associated with physiological intestinal peristalsis, 
antispasmodics such as hyoscine butylbromide (Bus-
copan®) or drotaverine hydrochloride (No-spa®) are 
used during the study [1]. If Buscopan® is given, it is 
necessary to collect a history of glaucoma because its 
use is contraindicated in patients with this condition.
Correct patient preparation is assessed on the 
basis of the first sequences of the MRI examination. 
A properly prepared small intestine should be about 
2.5-3 cm wide. This is important because of the risk 
of false-negative results (oversight) or false-positive 
results (a collapsed intestine may suggest thickening 
of its wall). Figures 1 and 2 show correct and abnor-
mal bowel filling with an orally administered contrast 
agent, respectively.
PREPARATION OF THE PATIENT  
FOR MR ENTEROCLYSIS
MR enteroclysis is a  study in which the contrast 
agent is administered through an inserted naso-intes-
tinal probe, the end of which should be placed in the 
duodenum near the Treitz ligament [1, 4-7]. The correct 
position of the probe should be confirmed by radio-
logical examination – fluoroscopy, using ionising radi-
ation. Therefore, it is definitely a rarely chosen method 
for imaging of the small intestine in paediatrics.
The contrast medium is administered by means of 
a pump compatible with the MR apparatus at a rate 
of about 80-200 ml/min.
METHOD OF CONDUCTING  
THE MR EXAMINATION
A patient properly prepared by the nurse for the 
examination (metal elements of clothing and jewel-
lery removed) is placed in the MRI scanner in a prone 
position, which further minimises intestinal peristal-
Figure 1. MR enterography study. Correct filling of the intestines 
with an oral contrast agent (source: MR MCD Voxel Laboratory 
archive)
Figure 2. MR enterography study. Incorrect filling of the intestines 
with an oral contrast agent (source: MR MCD Voxel Laboratory 
archive)
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tic movements. This position also allows for addition-
al widening of the intestinal lumen. 
The patient receives from the nurse earphones for 
noise suppression during the examination. The test 
takes about 40 minutes to complete. The key to a suc-
cessful examination is patient cooperation following 
instructions received from the examining technician. 
The correct way to hold one’s breath and remain still 
during the examination are parts of those instruc-
tions, both of which aim to reduce the formation of 
motion and respiratory artefacts, thus allowing ob-
taining good quality diagnostic images. During all ex-
ams the nurse supervises the patient’s wellness via 
a glass window and microphone connection.
Various MR sequences are used during MRI test-
ing, including dynamic (cine) sequences used to as-
sess intestinal motility.
In addition to oral/enteral contrasting agents, stan-
dard gadolinium preparations are administered by the 
nurse intravenously. They support diagnostic possi-
bilities in both MRI methods, MR enteroclyses and MR 
enterographies, aiding the process of assessment of 
the normal gastrointestinal mucosa and assessment 
of pathologically changed intestinal walls (e.g. inflam-
matory, cancerous infiltration) [5-8]. Table 2 shows the 
structures that are analysed during bowel MRI.
PATIENT CARE AFTER EXAMINATION
After the examination, the patient remains with 
the intravenous puncture under the care of a nurse 
for about 20-30 minutes. This is due to the possibility 
of side effects in patients associated with both oral 
and intravenous contrast media administration.
Complications after administration of oral con-
trast agents include diarrhoea (caused by the rapid 
displacement of water into the lumen of the gastro-
intestinal tract), as well as blood pressure drop. If this 
occurs, a patient requires longer observation, blood 
pressure monitoring, and intravenous administration 
of electrolyte-containing fluids.
Table 2. Structures analysed in the bowel MRI examinations
No. Analysed structure Analysis
1. The thickness of the intestinal wall With correctly inflated walls should be about 1-3 mm. Thickening 
of the wall above 3 mm indicates a pathological process, e.g. in 
Crohn’s disease, ischaemic diseases, or graft versus host disease
2. Layering of the intestinal wall Crohn’s disease staging 
3. Narrowing, obstruction Determination of the severity
4. Gastrointestinal fistulas, gastrointestinal adipose 
tissue, its degree of infiltration, presence of abscesses
Determination of the severity
5. Encapsulated or free fluid in the abdomen Determination of the severity
6. Lymph nodes Determination of the severity
